Cellulase variants
Structurally modified cellulase variants with specific amino acid changes improve antigreying performance, addressing the limitations of existing cellulases in detergent applications.
Patent Information
- Application Number
- PCT/FI2025/050439
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-27
- Filing Date
- 2025-08-21
- Publication Date
- 2026-03-05
AI Technical Summary
Existing cellulases used in commercial applications lack specific properties that enhance their suitability for desired purposes, particularly in detergent applications for antigreying performance.
Cellulase variants with structural modifications, such as amino acid substitutions and truncations in specific regions like positions 37, 236, and 239, and loop truncations, are developed to improve antigreying performance.
The modified cellulase variants exhibit enhanced antigreying performance compared to commercially available cellulases, providing better fabric care and cleaning effects.
Smart Images

Figure FI2025050439_05032026_PF_FP_ABST
Abstract
Description
[0001]CELLULASE VARIANTS FIELD OF THE INVENTIONThe present invention relates to cellulase variants, to products containing the cellulasevariants, and methods for manufacturing them.BACKGROUND OF THE INVENTION Cellulases or cellulolytic enzymes are enzymes involved in hydrolysis of cellulose. In the textile industry, cellulases are used in denim finishing to create a fashionable stonewashed appearance in denim cloths in a biostoning process, and they are also used toclean fuzz and prevent formation of pills on the surface of cotton garments. In detergentindustry cellulases are used to brighten colors and to prevent graying, pilling of garments,and to improve cleaning. Cellulases are further used in food industry and animal feedmanufacturing, and they have a great potential in biomass hydrolysis and in the pulp andpaper industry, where they can increase fibrillation, or support deinking, by being added e.g. after cooking and before bleaching in a Kraft Pulp process, or after bleaching in a Kraft pulp process, or being added after repulping and before refining to a pulp slurry in the production of tissue, paper or paper board. Although cellulolytic enzymes have been used successfully in commercial applications formany years, a need still exists for new cellulases with altered properties that make themparticularly suitable for a desired purpose. SUMMARY OF THE INVENTION The appended claims define the scope of protection. Any example and / or technical description of an apparatus, system, product and / or process in the description and / or drawing which is not covered by the claims is presented herein not as an embodiment of the invention but as an example useful for understanding the invention. The inventors have surprisingly found that certain structural modifications can be made in an amino acid sequence of a cellulase and achieve a cellulase variant having cellulosedegrading activity in liquid detergents. Additionally, some structural modifications to thecellulase were found to improve antigreying performance of the resulting variant in liquiddetergents, when compared to the performance of the parent enzyme without said modifications.According to a first aspect of the invention is provided a cellulase variant comprising anamino acid sequence having at least 80% sequence identity with the SEQ ID NO: 1 [A. strumarium Cel7], and at least one structural modification selected from: an amino acidsubstitution in the amino acid sequence of the cellulase; and a truncation of a loop definedby the amino acids 274-289. The cellulase variant may have more than one of the above structural modifications. For example, it may have both a truncation or an absence of a loop, or a truncation or an absence of amino acid residues forming a loop in SEQ ID NO: 1, and additionally an amino acid substitution in the amino acid sequence of the cellulase. In an embodiment the amino acid substitution is in at least one position selected from 37, 236, and 239. These positions have a role in substrate binding.As evidenced by Examples below, the Cel7 cellulase (SEQ ID NO: 1) designated here asAS0, was successfully used as a parent enzyme (template cellulase) for designing andmanufacturing various cellulase variants with structural modifications. Substitutions, insertions, and deletions could be successfully introduced in the Cel7 backbone in thepositions specified herein, while retaining cellulolytic activity of the cellulase variant andallowing their production in host cells. Additionally, positions for structural modifications were identified that could be combined and that were shown to further improve antigreying performance of the cellulase variant. In an embodiment the cellulase variant has an increased antigreying performance compared to a cellulase having the SEQ ID NO: 1. The antigreying performance can bedetermined as described in Example 4 below.Further, the antigreying performance of the Cel7 cellulase without structuralmodification(s) was found to be increased, i.e. better, than that of commercially availablecellulase enzymes used as a reference (see Example 4).In an embodiment the cellulase comprises at least residues A37, D236, and A239. Theseresidues were shown to be important for cellulase performance in detergent applicationtests, and they could be altered by substitutions resulting into different cellulase activity inan antigreying assay. In an embodiment the cellulase comprises at least residues that correspond to the residues A37, D236, and A239 of SEQ ID NO: 1. In an embodiment the structural modification is one or more substitution selected from 37S / T / N, 236S / P / G, and 239G / S. In an embodiment the structural modification is one or more substitution selected from 37S / T / N, 236S / P / G, and 239G.In an embodiment the structural modification is a substitution 37S. In another embodimentthe structural modification is a substitution 37T. In another embodiment the structuralmodification is a substitution 37N. In an embodiment the structural modification is a substitution 236S. In anotherembodiment the structural modification is a substitution 236P. In another embodiment thestructural modification is a substitution 236G.In an embodiment the structural modification is a substitution 239G. In anotherembodiment the structural modification is a substitution 239S.In an embodiment the structural modification is a substitution of residues 236 and 239,preferably a substitution 236S / P / G and 239G / S, more preferably a substitution D236S / P / G and A239G / S. In an embodiment the structural modification is one or more substitution selected from A37S / T / N, D236S / P / G, and A239G / S. In an embodiment the structural modification is one or more substitution selected from A37S / T / N, D236S / P / G, and A239G. In an embodiment the structural modification is a modification in one or two positions and selected from 37S / T / N, 236S, and 239G, more preferably from A37S / T / N, D236S / P, and A239G. As the skilled person knows, a loop structure in a protein structure is a flexible and often unstructured segment within the three-dimensional structure of a protein. In the present cellulase the loop region defined by the amino acids 274-289 was shown to be important for cellulolytic activity in detergent applications, in particular to antigreying performance. In an embodiment the structural modification of the cellulase variant comprises a truncation of a loop defined by the amino acids 274-289, and the truncation comprisesdeleting one or more residues in the loop region 274-289 of the cellulase variant, therebymaking the overall structure of the protein less flexible. In another embodiment the truncation comprises substituting of one or more residues in the region 274-289 by one or more amino acids. When deleting loop region residues, or when replacing loop regionresidues by a shorter amino acid chain, the truncation results in a variant having a smallernumber of total amino acids compared to the parent.For clarity, in the present disclosure amino acid sequences of variants having truncationsor substitutions are discussed by referring to the original amino acid numbering of SEQ ID NO: 1.In another embodiment a loop defined by the amino acids 274-287, 275-289, or 275-287is truncated. In the present invention a truncation in such an amino acid region can bemade in the same manner as specified elsewhere for the loop defined by the amino acids 274-289. In another embodiment the truncation comprises deletion of one or more residues in the loop region 274-287 of the cellulase variant. In another embodiment the truncation comprises substituting one or more residues in the region 274-287 by one or more amino acids.In another embodiment the truncation of a loop comprises replacing, substituting, orchemically modifying one or more residues in the region 274-289 by one or more residues,or chemically modifying such that the loop structure is changed. For example 14, 13, 12,11, 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 residue(s) in the region 274-289 can be replaced by 1, 2,3, 4, 5, or 6 residue(s). Preferably the region 274-289 is shortened by the replacement,i.e. the number of replaced residues is larger than the number of the replacing residues.Preferably, the replacement is a replacement of consecutive amino acids in the region274-289.In a preferred embodiment the residues 274-289 are replaced by 1, 2, 3, 4, or 5 residues.Preferably they are replaced by an amino acid sequence GG, GPG, NRRG (SEQ ID NO:4), or NDTTG (SEQ ID NO: 5). In addition to the truncation of the loop, the cellulase variantmay include a substitution of at least one of the residues 37 and 236, such as a substitution to 37S / T and / or 236S / P / G.In a preferred embodiment the residues 276-289 are replaced by 1, 2, 3, 4, or 5 residues.Preferably they are replaced by amino acids GG, GPG, NRRG (SEQ ID NO: 4), or NDTTG(SEQ ID NO: 5), more preferably by GPG. In addition to the truncation of the loop, thecellulase variant may include a substitution of at least one of the residues 37 and 236, such as a substitution to 37S / T and / or 236S / P / G. In a more preferred embodiment the residues 276-287 are replaced by 1, 2, 3, 4, or 5 residues. Preferably they are replaced by amino acids GG, GPG, NRRG (SEQ ID NO: 4),or NDTTG (SEQ ID NO: 5), more preferably by GPG. In addition to the truncation of theloop, the cellulase variant may include a substitution of at least one of the residues 37 and 236, such as a substitution to 37S / T and / or 236S / P / G. In an embodiment the structural modification is a truncation of the loop defined by theamino acids 274-289, and the truncation is a substitution of the amino acids 274-289 by1-5 amino acids, or by 1-4 amino acids. In an embodiment the structural modification is a truncation of the loop defined by the amino acids 274-287, and the truncation is a substitution of the amino acids 274-287 by1-5 amino acids, or by 1-4 amino acids.In an embodiment the structural modification is a truncation of the loop defined by theamino acids 276-289, and the truncation is a substitution of the amino acids 276-289 by1-5 amino acids, or by 1-4 amino acids. In an embodiment the structural modification is a truncation of the loop defined by the amino acids 276-287, and the truncation is a substitution of the amino acids 276-287 by 1-5 amino acids, or by 1-4 amino acids. In an embodiment the structural modification is a truncation of the loop as defined above, and additionally a substitution in one, two, or three positions 37, 236, and 239, such as a substitution 37T / S, 236S / P / G, and / or 239G. In an embodiment the substitution is selected from (AS101) 274-287 replaced with NRRG (SEQ ID NO: 4), (AS102) 274-287 replaced with NDTTG (SEQ ID NO: 5), (AS103) 276-287 replaced with GG, and (AS104) 276-287 replaced with GPG. Additionally, thecellulase variant may include a substitution of at least one of the residues 37 and 236, such as a substitution to 37S / T and / or 236S / P / G.In a preferred embodiment the substitution is selected from (AS101) S274-K287 replacedwith NRRG (SEQ ID NO: 4), (AS102) S274-K287 replaced with NDTTG (SEQ ID NO: 5), (AS103) P276-K287 replaced with GG, and (AS104) P276-K287 replaced with GPG. Additionally, the cellulase variant may include a substitution of at least one of the residues 37 and 236, such as a substitution to 37S / T and / or 236S / P / G. In an embodiment the present cellulase variant is varied by making at least one substitution in position 37, 236, and / or 239. One, two, or three substitutions are preferred.In another aspect is provided a detergent comprising a cellulase enzyme having an aminoacid sequence having at least 80% sequence identity with the SEQ ID NO: 1 and / orpresent cellulase variant, and at least one surfactant. It was surprisingly found that thepresent cellulase can be used in a detergent composition to an advantage and to providea better antigreying performance compared to commercially available cellulases, and thatthe variants described herein provide additional advantages in such compositions andwhen compared to the parent enzyme or to the commercially available cellulases. In another aspect is provided a method of manufacturing a detergent composition comprising providing a cellulase enzyme having an amino acid sequence having at least 80% sequence identity with the SEQ ID NO: 1 and / or the present cellulase variant, and atleast one surfactant, and mixing to provide the detergent composition. The detergentcomposition can optionally be formulated to a desired formulation. In an embodiment the detergent is provided in a form of a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular orcompact powder, a granule, a paste, a gel, or a regular liquid, compact liquid, orconcentrated liquid. In an embodiment the detergent is a laundry detergent composition, preferably a liquid or solid laundry detergent composition. In an embodiment the detergent further comprises other enzymes selected from the group of proteases, amylases, cellulases, lipases, xylanases, mannanases, cutinases, esterases, phosphodiesterases, phytases, DNases, pectinases, pectate lyases, pectinolytic enzymes, carbohydrases, arabinases, galactanases, xanthanases,xyloglucanases, laccases, peroxidases, and oxidases with or without a mediator.In an embodiment the detergent further comprises at least one additive selected from thegroup of stabilizer, buffer, surfactant, builder, bleaching agent, mediator, anticorrosion agent, antiredeposition agent, caustic, abrasive, optical brightener, dye, pigment, and preservative. In another aspect is provided a method of producing the present cellulase variant, comprising culturing a recombinant host cell having genetic elements configured to express a polypeptide having the amino acid sequence of the present cellulase variant, and recovering the polypeptide. In another aspect is provided a method of producing the present cellulase enzyme, comprising culturing a recombinant host cell having genetic elements configured to express a polypeptide having at least 80% sequence identity with the SEQ ID NO: 1, and recovering the polypeptide. According to another aspect is provided a method for antigreying, stain removal, fiber care, and color care, biostoning, or biofinishing a fabric made of cotton fibres or a fabric made of fibres of other cellulose based material,comprising a step of contacting the present cellulase variant or the present detergent with the cotton containing fabric.In an embodiment the fibres of the other cellulose based materials include natural plantbased fibres semi-synthetic fibres, fibres which can be derived from regenerated cellulose and are known e.g. as viscose, rayon, lyocell, modal, cupro or others, and fibres which are mostly produced from a wood based material.According to another aspect is provided a method for antigreying, stain removal, fiber care,color care, biostoning, or biofinishing a cotton containing fabric, comprising a step of contacting the present cellulase, the present cellulase variant, or the present detergent, with the cotton containing fabric. In an embodiment the cotton containing fabric is a garment, fabric, or yarn containing cotton.According to another aspect is provided a method of generating a cellulase variantcomprising the steps of: (a) providing a template nucleic acid sequence of a template cellulase; (b) identifying by biocomputing means active site residues and loop region residues of the template cellulase; (c) generating variant nucleic acid sequences that encode candidate cellulase variants by modifying the template nucleic acid sequence by a modification, deletion, or addition of one or more amino acid in the active site residues and / or in loop region residues; (d) expressing the template nucleic acid sequence in a recombinant host cell to provide template cellulase enzyme; (e) expressing the variant nucleic acid sequences in a recombinant host cell to provide a candidate variant enzyme; (f) testing and scoring the candidate variant enzymes, and using the template cellulase enzyme as a reference, for production level in the host cell, and antigreying performance; and (g) selecting the candidate variant enzyme as the cellulase variant when the candidate variant enzyme reaches a predetermined scoring threshold value based on the performance in step (f). In an embodiment, in the method of generating a cellulase variant, the template nucleic acid sequence of the template cellulase encodes SEQ ID NO: 1. In an embodiment, in the method of generating a cellulase variant, the step (f) involves using a cellulase having the amino acid sequence SEQ ID NO: 1 as a reference to which the antigreying performance, and optionally the production level, is compared. In an embodiment the predetermined scoring threshold level is selected from 5%, 10%, 15%, 20%, 25%, 30%, 50%, 75%, 100%, 150%, 200%, 250%, 300%, compared to the reference. FIGURESFigure 1 shows an antigreying performance of AS0 and commercial cellulase incommercial liquid detergent 1. DETAILED DESCRIPTIONEnzymes are catalytic proteins. Proteins are polypeptides. Polypeptides are long chainsof amino acids linked by amide bonds. In the present disclosure, peptides are considered as being molecules composed of up to 20 amino acids, and polypeptides are molecules composed of more than 20 amino acids. The generally accepted IUPAC single letter abbreviations for amino acids and their side chains in polypeptides are used herein.In an embodiment the cellulase variant is a recombinant cellulase variant. The termrecombinant means that it has been modified chemically and / or structurally from its nativestate, and / or produced by using recombinant technology or by gene manipulationtechnology. Recombinant proteins typically differ from a native sequence by one or moreamino acids and / or because they are fused with one or more heterologous sequences.The articles “a” and “an”, as well as “another” and “further”, are meant to refer to one or tomore than one, that is to one or at least one, including several, of the grammatical object of “a”, “an” or “another”.In an embodiment the present method of producing enzymes or the cellulase variant is anindustrial scale method which optionally excludes for example analytical methods for research purposes. In an embodiment any of the present methods is carried out in the sequence specified ina claim, aspect, or embodiment.The word “comprise” and variations thereof such as “comprises” and “comprising” aremeant inclusively and include additional possible components that are technically compatible as understood by a person skilled in the art. These terms also may in certain embodiments include their narrow meaning “consisting of”.Recitation of ranges of values herein are merely intended to serve as a way of referringindividually to each separate value falling within the range, unless otherwise indicated. Each separate value is thus disclosed in the specification as if it were individually recited. In an embodiment, and as is understood by the skilled person in the context in which the expression is used, an open-ended range such as “less than 10” is to be construed as arange disclosing values below 10, but above 0. Such a range can be understood to include a lower limit of e.g.0.0001, 0.001, 0.1, or 1 depending on the context. A lower limit of an open ended range can also be determined by the skilled person such that at least one technical effect is observable or measurable, thereby excluding insignificant trace amounts.In embodiment the cellulase variant has cellulase activity. Cellulase activity means havingcellulolytic activity that catalyzes the hydrolysis of 1,4-beta-D-glucosidic linkages in cellulose. Cellulolytic activity can be determined according to the procedure described in the Examples. The term “parent” or “parent cellulase” or “template cellulase” means a polypeptide withcellulolytic activity to which a structural modification or alteration is made to produce thecellulase variant of the present invention. In a preferred embodiment the parent is apolypeptide having at least 80%, 85%, 90%, or 95% sequence identity with SEQ ID NO: 1, and structural modifications can be made in the parent sequence to obtain the presentcellulase variants. Preferably the parent and the cellulase variant both have cellulolyticactivity. The present cellulase variant preferably comprises a sequence that is at least 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%,97%, 98%, or at least 99%, but less than 100% identical to SEQ ID NO:1. In someembodiments, the cellulase variant sequence comprises at least one mutation orsubstitution. As used herein, “identity” means the percentage of exact matches of aminoacid residues between two aligned sequences over the number of positions where thereare residues present in both sequences. When one sequence has a residue with nocorresponding residue in the other sequence, the alignment program allows a gap in thealignment, and that position is not counted in the denominator of the identity calculation.Identity is a value determined with the Pairwise Sequence Alignment 35 tool EMBOSSNeedle at the EMBL-EBI website (www.ebi.ac.uk / Tools / psa / emboss_needle / ) with thefollowing parameters: BLOSUM62, Gap open 10, Gap extend 0.5.A cellulase variant according to the invention — and a gene encoding the enzymeaccording to the invention — can be derived from polypeptides and nucleic acids found innature, or engineered from a synthetic polypeptide or synthetic nucleic acid with sequence information derived from nucleic acids or polypeptides found in nature. Such sequence information can be derived from more than one sequence found in nature, for example calculation of a common ancestor sequence, calculation of a synthetic sequence from an alignment of known homologous sequences, particularly calculation of the most frequent amino acid at each position and derivation of a consensus sequence.Furthermore, a cellulase variant according to the invention — and a gene encoding theenzyme according to the invention — can contain one or more additional alterations orstructural modification without a loss of function, or with a modified function. A functionalenzyme can be verified for example by an enzyme activity measurement. Examples of such structural modifications and alterations are insertions, deletions and / or substitutions, preferably conservative substitutions, relative to a polypeptide or nucleic acid found in nature. The experimental exchangeability of amino acids in proteins has been reviewed by Yampolsky and Stoltzfus in Genetics 2005 pp 1459-1472 and can be applied to the enzymes used in the present invention. Amino acid substitutions are designated herein by indicating their position and a single letter code separated by a slash, e.g.50E / D means substitution in position 50 to E or D.Similarly, a substitution E50D means a substitution of E in position 50 to D. A substitutionfrom E to D is an example of a conservative substitution, because E and D are both acidic amino acids that differ only in one methylene spacer in their side chains. Further examples of the conservative substitutions are substitutions within the group of basic amino acids (e.g. R / K / H), acidic amino acids and their amides (e.g. E / D / N / Q), aromatic amino acids (e.g. W / F / Y), hydrophobic amino acids (e.g. F / L / I / V / A / M), tiny amino acids (e.g. G / A / S), medium amino acids (e.g. T / S / A / V / C), charged amino acids (e.g. E / D / R / K / H) and other polar amino acids (e.g. S / T / N / Q / H). Beside substitutions by the twenty canonical amino acids, also other genetically encoded amino acids, for example selenocysteine and pyrrolysine, and so-called unnatural amino acids can be incorporated in proteins. By stepwise solid-phase peptide synthesis any available amino acid can be incorporated in peptides, which can be chemically ligated to larger peptides and polypeptides, to produceproteins and enzymes. Thus, in an embodiment a substitution in the cellulase variant is aconservative substitution, which substitution is likely to have only a small effect on the structure and / or function of the enzyme. In another embodiment the substitution is a non- conservative substitution, which may have a bigger effect on the structure and / or function of the enzyme. An effect of a substitution to the present enzyme can be evaluated by computationalmeans and experimentally by analysing structure and / or antigreying performance of theenzyme. The antigreying performance can be tested according to the washing test ofExample 4, 5 or 6. The antigreying performance of the present enzymes could not bepredicted base on the amino acid sequence, but required experimental analysis carriedout according to the above Examples. Furthermore, the present cellulase variant can be a fusion polypeptide in which anotherpolypeptide and / or oligopeptide is fused to the amino-terminus and / or carboxyl-terminusof a polypeptide. Examples of such oligopeptides and polypeptides include poly histidinetags, signal peptides, linkers, binding domains, antibodies, chaperones, fluorescent proteins and enzymes. The terms “depilling” (removal of pilling) and “color revival” are typically used to describe the cellulase variant’s effects on old, used cotton textiles. The terms “antipilling” (prevention of pilling), “color maintenance” or “color care” are typically used to describe cellulase effects on new garments. The effect of fiber and color care properties can be detected by visible and measurable decrease of lightness (i.e. increase of darkness) or change in color of colored cotton textiles exposed to repeated washing cycles. Standardized tests monitors of prepilled and unpilled, new fabrics are commercially available. The cellulase variant is especially useful in detergent applications as an antigreying agent.As used herein, the term “antigreying performance” or “antigreying effects” or “antigreyingactivity” mean antiredepositioning and pigment removal properties. With increasingnumber of wash cycles pigments, particles, soluble soils, salts, and other material can adhere on the textile fibers, most likely in those areas where cotton fibers are damaged.This can cause a greying effect of especially white fabrics and / or darkening or yellowingof white cotton textile. Without being bound by a theory, the cellulase variant hydrolyzes damaged cotton fibers at random positions of the cellulose polymer having an amorphous structure, resulting into a removal of fibers with attached particles or that have a higher accessibility for surfactants, and therefore providing a whitening or antigreying effect. In addition to the antigreying effect, traces of cellulosic material in the washing liquor may be digested, preventing the adhesion of such fibers on the cotton surface of the garment. These effects are called antigreying or antiredeposition, and they can be evaluated using optical measurements. Suitable test methods are generally known in the art and are typically based on using artificial ballast soil systems with standard white test fabrics in repeated washing cycles in washing machines. The antigreying effect can be tested also by a single wash as stressed test using redeposition liquid based on carbon black. The cellulase variants may also be useful in finishing processes of the textile industry, such as biofinishing of fabrics, garments or yarn. As used in the present context, the expression “biofinishing” (also called depilling, defuzzing, dehairing or biopolishing) refers to the use of the variant enzymes in a controlled hydrolysis of cellulosic fibers in order to modify the fabric or yarn surface in a manner that permanently prevents the tendency for pilling, improves fabric handle like softness and smoothness, clears the surface structure by reducing fuzzing. Biofinishing results in clarification of colors, improves the drapability of the fabric and improves moisture absorbability, which may further improve also thedyeability. Biofinishing may be performed before, after, or at the same time as dyeing.Enzymatic depilling can be carried out at any stage during textile wet processing, preferably after optional desizing and / or bleaching, and similar conditions as in biostoning can be used. Textiles in garment form can be also treated. The cellulase variants may be used in biostoning of denim. As used in the present context, the expression “biostoning” of fabric or garment means the use of enzymes in place of, or in addition to, pumice stones for the treatment of fabric or garment, especially denim to obtain an aged or worn look. The term “aged or worn look” means that as a result of uneven dye removal, there are contrasts between dyed areas and areas from which dye has been removed. The liquor ratio (the ratio of the volume of liquid per weight of fabric) in both biostoning and biofinishing may range from about 3:1 to 20:1, preferably 5:1 to 10:1. The treatment time can vary between 15 min to 90 min and preferably between 30 min to 60 min. The enzyme dosage depends on the type of the fabrics, machinery, process conditions (pH, temperature, liquor ratio, treatment time, denim load, process scale) and type of the enzyme preparation or composition. Typical process parameters for e.g. industrialbiofinishing are pH 4.5 – 8 at temperature of 40 – 65°C. A person skilled in art is capablein defining suitable dosages and conditions when using the present cellulase variant.In other applications that employ the cellulolytic or antigreying performance of the presentcellulase variant, it is preferred to use an effective amount of the cellulase variant. The skilled person is capable of determining a suitable effective amount depending on theapplication and taking into account the process conditions and the formulation in whichthe cellulase variant is provided, including the specific activity of the cellulase variant in the formulation. When the present cellulase variant is used to degrade cellulose, cellulosic material is reacted with the present cellulase variant under suitable conditions, such as appropriate pH, and temperature, and the reaction is allowed to continue for a time sufficient for the cellulolytic reaction to take place, whereby at least partially hydrolyzed cellulosic material is obtained. The cellulase variant may be added to detergent compositions to improve textile cleaning, for instance by removal of pigment dirt and by antiredeposition and antigreying. The cellulase variant may also improve fiber and color care properties by prevention and removal of fuzz and pills resulting in brightening or freshening of colors and softening. In detergents, the amount of the cellulase variant can vary depending on the desired amount of cellulase activity.A detergent for use as a solid laundry detergent, may include 0.000001% - 5%, such as0.000005-2%, such as 0.00001%-1%, such as 0.00001%-0.1% of variant cellulase polypeptide by dry weight of the composition. A detergent for use as a laundry liquid, may include 0.000001%-3%, such as 0.000005%- 1%, such as 0.00001%-0.1% of variant cellulase polypeptide by weight of the composition. A detergent for use in automatic dishwash, may include 0.000001%-5%, such as 0.000005%-2%, such as 0.00001%-1%, such as 0.00001%-0.1% of variant cellulase polypeptide by weight of the composition. In an embodiment the detergent is in the form of a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact, or concentrated liquid. In one embodiment the detergent is a laundry detergent composition, preferably a liquid or solid laundry detergent composition. The cellulase variant and / or the detergent may be used for treating any cellulosic material. In the present context, “cellulosic material” refers to any material comprising cellulose or derivatives thereof as a significant component. Such a material may be textile material, plants or material of plant origin used in food or animal feed, plant material for oil extraction, or wood-derived mechanical or chemical pulp or secondary fiber. The use or amethod involving such use comprises contacting the material to be treated with aneffective amount of the present variant or detergent. In an embodiment the present cellulase variant is used in a method of making paper orpaper board, wherein the method comprises: providing a cellulase compositioncomprising: cellulase; adding the cellulase composition to a pulp slurry to produce atreated pulp slurry; and refining the treated pulp slurry to a desired freeness; and forminga paper or paperboard. In an embodiment the present cellulase variant is used in method of producing dissolvingpulp comprising the steps of: i) treating unbleached, or partially bleached, or alkalineextracted dissolving pulp, with one or more cellulases (X stage); and ii) bleaching ofunbleached / partially bleached / alkaline extracted pulp; and iii) optionally performingalkaline extraction of unbleached / partially bleached / alkaline extracted pulp; and therebygenerating dissolving pulp with reduced viscosity. In the above method the cellulase is preferably the present cellulase variant or detergent. In an embodiment the variant and / or the detergent is used to treat wood-derived pulp, chemical pulp, paper, paperboard, or secondary fiber. Preferably the present cellulase variant has an improved antigreying performance compared to the parent Cel7 cellulase. The improved antigreying performance can be analysed and confirmed by the method of Example 4, 5 and 6.In an embodiment the antigreying performance can be analysed by washing cottonswatches with liquid detergent in a redeposition liquid based on carbon black in thepresence of a cellulase variant, measuring reflectance of the swatches after the wash, andcalculating antigreying performance of the cellulase variant based on a reflectancedifference to a washing without the cellulase variant. The improved antigreyingperformance of the variant can be verified by comparing to the reflectance differenceobtained by using a reference enzyme such as the parent enzyme Cel7 from which thepresent cellulase variants derived. Some further embodiments are described below: Embodiment 1. A cellulase variant comprising an amino acid sequence having at least 80% sequence identity with the SEQ ID NO: 1, and at least one structural modificationselected from; a truncation of a loop defined by the amino acids 274-289; at least a partialabsence of amino acids corresponding to positions 274-289; and an amino acidsubstitution in the amino acid sequence of the cellulase. Embodiment 2. The cellulase variant of embodiment 1, wherein the structural modification is one or more substitution selected from 37S / T / N, 236S / P / G, and 239G / S. Embodiment 3. The cellulase variant of embodiment 1 or 2, wherein the structural modification is one or more substation selected from A37S / T / N, D236S / P / G, and A239G / S. Embodiment 4. The cellulase variant of embodiment 2 or 3, wherein the structural modification is a modification in one or two positions selected from 37S / T / N, 236S / P, and 239G, more preferably from A37S / T / N, D236S / P, and A239G. Embodiment 5. The cellulase variant of any one of the embodiments 2-4 having an increased antigreying performance.Embodiment A1. A cellulase variant comprising an amino acid sequence havingat least 80% sequence identity with the SEQ ID NO: 1, and at least one struc-tural modification selected from; a truncation of a loop defined by the aminoacids 274-289; at least a partial absence of amino acids corresponding to po-sitions 274-289; and an amino acid substitution in the amino acid sequence ofthe cellulase.Embodiment A2. the cellulase variant of embodiment A1, wherein the structuralmodification is one or more substitution selected from 37S / T / N, 236S / P / G, and239G / S. Embodiment A3. The cellulase variant of embodiment A1 or A2, wherein thestructural modification is one or more substitution selected from A37S / T / N,D236S / P / G, and A239G / S. Embodiment A4. The cellulase variant of embodiment A2 or A3, wherein the structural modification is a modification in one or two positions selected from 37S / T / N, 236S / P, and 239G, more preferably from A37S / T / N, D236S / P, and A239G. Embodiment A5. The cellulase variant of any one of embodiments A2-A4 having an increased antigreying performance compared to a cellulase having the SEQ ID NO: 1. Embodiment A6. The cellulase variant of embodiment A1, wherein the structural modification is a truncation of the loop defined by the amino acids 274-289, and wherein the truncation is a substitution of amino acids 274-289 by 1-4 amino acids. Embodiment A7. The cellulase variant of embodiment A6, wherein the substitu- tion is selected from (AS101) S274-K287 replaced with NRRG (SEQ ID NO: 4), (AS102) S274-K287 replaced with NDTTG (SEQ ID NO: 5), (AS103) P276- K287 replaced with GG, and (AS104) P276-K287 replaced with GPG.Embodiment A8. A detergent comprising a cellulase enzyme having an aminoacid sequence having at least 80% sequence identity with the SEQ ID NO: 1and / or the cellulase variant of any one of the embodiments A1-A7, and at leastone surfactant. Embodiment A9. The detergent of embodiment A8, wherein the detergent is pro- vided in a form of a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact pow- der, a granule, a paste, a gel, or a regular liquid, compact liquid, or concentrated liquid. Embodiment A10. The detergent of embodiment A8 or A9, wherein the detergent is a laundry detergent composition, preferably a liquid or solid laundry detergent composition. Embodiment A11. The detergent of any one of embodiments A8-A10, wherein the detergent further comprises at least one other enzyme selected from the group of proteases, amylases, cellulases, lipases, xylanases, mannanases, cu- tinases, esterases, phosphodiesterases, phytases, DNases, pectinases, pec- tate lyases, pectinolytic enzymes, carbohydrases, arabinases, galactanases, xanthanases, xyloglucanases, laccases, peroxidases, and oxidases with or without a mediator. Embodiment A12. The detergent of any one of the embodiments A8-A11 further comprising at least one additive selected from the group of stabilizer, buffer, surfactant, builder, bleaching agent, mediator, anticorrosion agent, antiredepo- sition agent, caustic, abrasive, optical brightener, dye, pigment, and preserva- tive. Embodiment A13. A method of producing the cellulase variant of any one of the embodiments A1-A7 comprising culturing a recombinant host cell having ge- netic elements configured to express a polypeptide having the amino acid se- quence of the cellulase variant of any one of the embodiments 1-7, and recov- ering the polypeptide. Embodiment A14. A method for antigreying, stain removal, fiber care, color care, biostoning, or biofinishing a cotton containing fabric, comprising a step of con- tacting the cellulase variant according to any of embodiments A1-A7, or the detergent according embodiments A8-A12, with the cotton containing fabric. Embodiment A15. The method of embodiment A14, wherein the cotton contain- ing fabric is a garment, fabric, or yarn containing cotton. Embodiment A16. A method of generating a cellulase variant comprising the steps of: (a) providing a template nucleic acid sequence of a template cellulase; (b) identifying by biocomputing means active site residues and loop region residues of the template cellulase; (c) generating variant nucleic acid sequences that encode candidate cellu- lase variants by modifying the template nucleic acid sequence by a modifi- cation, deletion, or addition of one or more amino acid in the active site residues and / or in loop region residues; (d) expressing the template nucleic acid sequence in a recombinant host cell to provide template cellulase enzyme; (e) expressing the variant nucleic acid sequences in a recombinant host cell to provide a candidate variant enzyme; (f) testing and scoring the candidate variant enzymes, and using the tem- plate cellulase enzyme as a reference, for production level in the host cell, and antigreying performance; and (g) selecting the candidate variant enzyme as the cellulase variant when the candidate variant enzyme reaches a predetermined scoring threshold value based on the performance in step (f).In an embodiment, in step (f) the testing and scoring for antigreying performanceis carried out by measuring the cellulase activity according to the method described in Example 5, and scoring by the following scheme:0 (no difference to AS0): + / - 1,5 units (ΔY)+ (better than AS0): +1,5 - 3,5 units (ΔY)(clearly better than AS0): +3,5 - 5,5 units (ΔY)(highly improved over AS0): >5,5 units (ΔY) - (weaker performance than AS0): <-1,5 units (ΔY) In an embodiment, step (g) comprises selecting a scoring threshold of 0, +, ++, and / or +++. Preferably a scoring threshold of at least + is selected. More prefera- bly, a scoring threshold of at least ++ is selected. Most preferably, a scoring thresh- old of +++ is selected. Embodiment A17. The method of embodiment A16, wherein the template nucleic acid sequence of the template cellulase encodes SEQ ID NO: 1. SEQUENCE LISTINGSSEQ ID NO: 1 is an amino acid sequence of mature AS0 cellulase without signalsequence, 415 amino acids.SEQ ID NO: 2 is a nucleotide sequence encoding the amino acid sequence of mature AS0cellulase, 1248 bp.SEQ ID NO: 3 is an amino acid sequence of the full-length 50K Melanocarpus albomyces cellulase.SEQ ID NO: 4 is an amino acid sequence NRRG.SEQ ID NO: 5 is an amino acid sequence NDTTG.SEQ ID NO: 6 is an amino acid sequence STPNPPQNGKGHNK. SEQ ID NO: 7 is an amino acid sequence PNPPQNGKGHNK. EXAMPLES Variant design The cellulase variant or mutant endoglucanase of the present invention was designed based on sequence and structure comparison of the Endoglucanase I (Cel7B), Humicola insolens 2A39_A and Talaromyces emersonii 6SU8_1. Also, amino acid sequences of other endoglucanases I were used in comparisons. A change in the amino acid sequence of the cellulase variant may be obtained by constructing a modified nucleotide sequence or DNA sequence by using genetic engineering. As a result, a modified nucleotide sequence is obtained, which encodes the variant or mutant polypeptide of the invention. The methods for modifying the nucleotide sequences include e.g. site-directed and random mutagenesis. For site-directed mutagenesis, a method based on protein structure, a good understanding of the structure- function relationship would be beneficial. In the absence of such deep understanding,methods based on random mutagenesis may be used. For example, as disclosed inSambrook and Russell (2001) oligonucleotide-directed mutagenesis for changing the base sequence of a segment of the coding DNA may be used to test the role of residues in the structure and catalytic activity of a protein. In the absence of a three-dimensional structure, this type of protein engineering relies on educated guesses concerning the structure of the protein and contribution of individual residues to protein stability and function. Specific examples of cellulase variants according to the present invention are described herein. The skilled person understands that the specific examples are merely illustrativeexamples of structural modifications that can be made to make cellulase variants. Theexamples below provide methods that the skilled person can use to manufacture and identify substitution sites that provide effective cellulase variants.Standard molecular biology methods were used in the isolation and enzyme treatmentsof DNA (e.g. isolation of plasmid DNA, digestion of DNA to produce DNA fragments), inE. coli transformations, sequencing etc. The basic laboratory methods used were eitheras described by the enzyme, reagent or kit manufacturer or as described in the standardmolecular biology handbooks, e.g. Sambrook and Russell (2001) or as described in thefollowing examples. Example 1. Backbone screening / Bio IT sequence searchIn order to identify novel cellulase candidates a protein family analysis was conducted.The Glycoside Hydrolase Family 7 (GH7 family) was chosen for the search.To start the protein family analysis of GH7, all proteins belonging to the protein family were collected. Proteins were retrieved by homology-based BLAST searches and by proteinmotif search. The query sequence in the BLAST searches was 50K (SEQ ID NO: 3).The BLAST searches were conducted against several sequence databases, to get maximum coverage of the available sequences. The following databases were queried using command line BLAST: NCBI protein databases (nr, pdbaa), NCBI nucleotide databases (nt, env_nt), Uniprot protein database (including both SwissProt and TrEMBL), proprietary genomes of fungal and bacterial species, and patent sequence data via SequenceBase i.e. protein sequences from Thomson Reuters GENESEQ™, USGENE® , WOGENE. The BLAST searches were conducted using a shell script in a Linux environment. The script goes through the databases and for each database conducts a batch BLAST search using all query proteins sequences simultaneously. E-value threshold of 1e-30 was used. The BLAST was requested to return 10000 best hits for each query. Otherwise default parameters were used. The script then retrieved the DNA / AA sequence of matching hits. For BLAST hits from nucleotide databases a specially built script was used to process the xml-format BLAST output and extract the matching portion as an amino acid sequence.Glycoside Hydrolase Family 7 proteins in Sordariales genomes were downloaded fromthe Joint Genome Institute website (https: / / mycocosm.jgi.doe.gov / ). After retrieval of the candidate sequences, a phylogenetic tree was constructed to get an understanding of the diversity among the retrieved sequence. The construction of the phylogenetic tree consisted of clustering of sequences to remove redundancy, followed by multiple sequence alignment and building of the phylogenetic tree. The protein sequences were clustered before the multiple sequence alignment and phylogenetic tree construction. This was done to remove the redundancy. To get an even coverage of the sequence space, the sequences were clustered to 95% identity using the CD-HIT clustering program ((http: / / weizhongli-lab.org / cd-hit / ). The selected candidates were aligned using MAFFT (https: / / mafft.cbrc.ip / aiignment / software / ), a multiple sequence alignment program. A phylogenetic tree was built based on the multiple sequence alignment using FastTree (http: / / www.microbesoniine.org / fasttree / ) algorithm. FastTree infers approximately- maximum-likelihood phylogenetic trees from alignments of nucleotide or protein sequences. Candidate sequences for expression were selected from the branch containing the 50K cellulase. This branch had 474 sequences of fungal origin. Altogether 20 sequences were selected for testing.20 genes were expressed in T. reesei (Example 2). Expression levels of recombinantenzymes were determined by measuring NCU activity (Example2). Enzyme applicationperformance was evaluated (Example 4). Achaetomium strumarium (SEQ ID NO: 1)cellulase was selected for further enzyme engineering.Example 2. Production of Achaetomium strumarium Endoglucanase I inTrichoderma reeseiThe cellulase gene, designated here as AS0 (nucleic acid sequence SEQ ID NO: 2,corresponding to amino acid sequence SEQ ID NO: 1), encoding Achaetomiumstrumarium Endoglucanase I, was ordered as synthetic gene with Trichoderma reeseicodon usage.For production of recombinant AS0, the gene was fused (direct fusion) to T. reesei cbh1(cellobiohydrolase 1) promoter in expression cassette. The transcription was terminatedby the T. reesei cbh2 (cellobiohydrolases 2) terminator. Synthetic gene encodingacetamidase (AmdS) was used as a transformation marker in the plasmid as described inPaloheimo et al.2003. In addition, the expression plasmid contains cbh13’ and 5’ flankingregions for optionally targeting the expression vector into the cbh1 locus.The plasmid including the expression cassette was transformed to T. reesei usingprotoplast transformation. The transformants were selected on plates containingacetamide as the sole nitrogen source. The T. reesei host strain used is lacking four mainendogenous cellulases: CBHI / Cel7A, CBHII / Cel6A, EGI / Cel7B and EGII / Cel5A. The transformations were performed according to (Penttilä et al., 1987), with the modifications described in (Karhunen et al., 1993). Additionally, CRISPR-CAS technology can be used in transformations (Rantasalo, A. et al., 2019). Transformants were purified on selection plates through single conidia prior to sporulating them on potato dextrose agar (PDA). The endoglucanase production of the transformants was analyzed from the culture supernatants of shake flask cultivations (50 mL). Transformants were grown for 7 days at 30ºC, 250rpm in a complex cellulase-inducingmedium (Joutsjoki et al., 1993) buffered with 5 % (w / v) KH2PO4 at pH 5.5 to obtain materialfor the application tests (Example 4). The enzyme activity of the recombinant protein was measured from the culture supernatant as the release of reducing sugars from carboxymethylcellulose (3% CMC) at 50°C in 50mM HEPES buffer pH 7.0 essentially as described by Bailey and Nevalainen, 1981; Haakana, et al, 2004 (NCU activity). Production of the recombinant protein was also detected from the culture supernatant by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).Example 3. Production of Achaetomium strumarium AS variants inTrichoderma reeseiStandard molecular biology methods were used as described in Example 2. The parentalmolecule for construction of Achaetomium strumarium Endoglucanase I variants is thewild type cellulase AS0 (nucleic acid sequence SEQ ID NO: 2, corresponding to amino acid sequence SEQ ID NO: 1). The endoglucanase genes encoding the designed endoglucanase variants (Table 1) were ordered as synthetic genes with Trichodermareesei codon usage. Expression plasmids were constructed, and recombinant proteinsproduced as described in Example 2.Table 1. The synthetic genes used in construction of the expression cassettes forproduction of AS endoglucanase variants in T. reesei. Amino acid positions are numberedby correspondence with the mature amino acid sequence without signal sequence (SEQID NO: 1). VariantAmino acid change in parent AS0Variant structural modification code cellulase AS45 A37T 37TAS47 A37N 37NAS51 A37S, P216K 37S, 216KAS52 A37S, V389R 37S, 389RAS53 A37S, N58D, V389R 37S, 58D, 389RAS57 D236S 236SAS58 D236P, A239G 236P, 239GAS59 D236G 236GAS60 P216K, T262R 216K, 262RAS62 P216K, T262R, V389R 216K, 262R, 389RAS64 N281K, D311R, T396K 281K, 311R, 396KAS65 N281K, K289R, T396K 281K, 289R, 396KAS66 N281K, K289R, D311R 281K, 289R, 311RAS73 A37S, A239S 37S, 239SAS83 A37S, D236S 37S, 236SAS84 A37S, D236P 37S, 236PAS85 A37S, D236G 37S, 236GAS86 A37T, D236S 37T, 236SAS87 A37T, D236P 37T, 236PAS88 A37T, D236G 37T, 236GAS89 A37N, D236S 37N, 236SAS90 A37N, D236P 37N, 236PAS91 A37N, D236G 37N, 236GAS92 A37S, D236S, A239G 37S, 236S, 239GAS93 A37S, D236P, A239G 37S, 236P, 239GAS94 A37S, D236G, A239G 37S, 236G, 239GAS95 A37T, D236S, A239G 37T, 236S, 239GAS96 A37T, D236P, A239G 37T, 236P, 239GAS97 A37T, D236G, A239G 37T, 236G, 239GAS98 A37N, D236S, A239G 37N, 236S, 239GAS99 A37N, D236P, A239G 37N, 236P, 239GAS100 A37N, D236G, A239G 37N, 236G, 239GAS101 S274-K287 STPNPPQNGKGHNK (SEQ274-287 replaced with NRRG (SEQ ID ID NO: 6)) replaced with NRRG (SEQ IDNO: 4) NO: 4) AS102 S274-K287 (STPNPPQNGKGHNK (SEQ274-287 replaced with NDTTG (SEQ ID ID NO: 6)) replaced with NDTTG (SEQ NO: 5) ID NO: 5) AS103 P276-K287 (PNPPQNGKGHNK (SEQ ID276-287 replaced with GG NO: 7)) replaced with GG AS104 P276-K287 (PNPPQNGKGHNK (SEQ ID276-287 replaced with GPG NO: 7)) replaced with GPG AS105 A37T, D236S, loop deletion [P276-K28737T, 236S, loop deletion [276-287 replaced with GPG] replaced with GPG] AS106 A37T, D236S, loop deletion [P276-K28737T, 236S, loop deletion [276-287 replaced with GPG], LCBM replaced with GPG], LCBM AS107 loop deletion [P276-K287 replaced withloop deletion [276-287 replaced with GPG], LCBM GPG], LCBM AS108 A37S, D236S, loop deletion [P276-K28737S, 236S, loop deletion [276-287 replaced with GPG], LCBM-Ins replaced with GPG], LCBM-Ins AS109 A37S, D236S, loop deletion [P276-K28737S, 236S, loop deletion [276-287 replaced with GPG], LCBM-Ins-3MUT replaced with GPG], LCBM-Ins-3MUTExample 4. Testing the antigreying performance of AS0 in Launder-Ometer incommercial liquid detergent 1AS0 produced in Trichoderma as described in Example 2 was tested for antigreyingperformance by a single wash method (40°C, 60 min, 16°dH) using carbon black (approx.0.15g / l) in a wash solution in addition to detergent (3.2 g / l). Commercial cellulase wasused as reference. Cotton interlock double jersey with optical brighteners (CN-42) supplied from CFT (Center for Testmaterials NV, the Netherlands) was used as test fabric. The fabric was first prewashed in a washing machine (15 min 50°C and 60 min at 60°C) and tumble dried, then cut to swatches of approx.14x14.5cm (total weight of 4 swatches 25g). As a source of carbon black RD-liq 01 from CFT containing 7 g of carbon black liquid (about 33% carbon black particles) in plastic bottles, that are normally intended for full scale washes in washing machine (one bottle per one single wash with test fabrics), were used. In this Example the method was adapted to small scale using approximately similar ratio of carbon black and water that would be in full scale. First a stock solution carbon black was prepared by placing an opened bottle of RD-liq 01 (i.e. about 2.3g carbon black particles) in a decanter flask containing 1 liter of deionized water. The solution was stirred with a magnetic stirrer for overnight until the contents of the bottle were totally released. After that 65 g of stock solution mixed with 935ml of synthetic tap water with hardness of 17.1°dH ending up to diluted carbon black solution having hardness of 16°dH and carbon black content approximately 0.15g / l (or 0.45g RD-liq 01). For synthetic tap water with hardness of 17.1°dH the following stock solutions were prepared in deionized water (Milli-Q or equivalent):Stock solution with 1000°d Calcium-hardness: CaCl2 x 2 H2O (1.02382.1000, Merck KgaA,Germany) 26.22g / lStock solution with 200°d Magnesium-hardness: MgSO4 x 7 H2O (1.05886.1000, MerckKgaA, Germany) 8.79g / l H2O NaHCO3 stock solution: NaHCO3 (1.06329.1000 Merck KgaA, Germany) 29.6g / l. 14.2ml CaCl2 solution, 14.2ml MgSO4 solution and 10.0ml of freshly made NaHCO3 solution were added in volumetric flask in the given order, made up to 1 liter with deionized water and mixed. Antigreying tests were performed in Atlas LP-2 Launder-Ometer as follows. Launder- Ometer was first preheated to 40°C. 60g of steel balls (diameter 0.6 cm), 0.79g of commercial liquid detergent described in Table 2, 250ml of diluted carbon black solution having hardness of 16°dH and diluted enzyme (<1.0ml) were added into 1.2 liter containers. After that, 4 swatches of prewashed test fabric CN-42 were added and the Launder-Ometer was run at 40°C for 60min with a rotation speed of 42rpm. Enzymes were dosed 0.2 activity units (NCU) per liter. Table 2. Composition of commercial liquid detergent 1 Ingredient (%)Anionic surfactants 15 – 30Nonionic surfactants, soap 5 – 15Boric acid 1 – 2.5Other ingredients: e.g. citric acid, builder, polyols, solvents, optical brighteners, perfumes, preservatives Water to 100%pH 7.5-8.5 After the cellulase treatment in Launder-Ometer, the swatches were first quickly rinsed separately under running tap water (ca. 20°C) to remove the steel balls, then rinsed separately under running water in specific cups containing holes for 3 times and finally dipped in a bucket containing water. After that the swatches were spin-dried in a washing machine and let to dry on a grid at room temperature. Enzyme treated fabrics and controls without enzyme were rinsed and spin-dried separately to avoid contamination. Antigreying performance of cellulase was evaluated by measuring reflectance of test fabrics by Konica Minolta CM3610A spectrophotometer as Y-value (illuminant D65 / 10°, 420nm cut). Cellulase performance was calculated as ΔY (delta Y), which means value Y of enzyme treated fabric minus value Y of fabric treated with carbon black and detergent containing washing liquor without enzyme (enzyme blank, control). Values were the average of 4 swatches. The higher the Y or ΔY value, the better the antigreying effect and whiteness of the fabric.Results in Figure 1 show that AS0 is a cellulase with surprisingly good antigreyingperformance. Figure 1 shows that AS0 has higher antigreying performance compared tothat of commercial cellulase.Example 5. Screening the antigreying performance of AS0 variants AS45-AS59,AS73 in Launder-Ometer in commercial liquid detergent 1 AS0 variants (AS45-AS59, AS73) produced in Trichoderma as described in Example 3were tested for antigreying performance by a single wash method (40°C, 60 min, 16°dH)using carbon black (approx.0.15g / l) in a wash solution in addition to detergent (3.2 g / l). Parental cellulase AS0 was used as reference. Cotton interlock double jersey with optical brighteners (CN-42) supplied from CFT (Center for Testmaterials NV, the Netherlands) was used as test fabric. The fabric was first prewashed in a washing machine (15min 50°C and 60min at 60°C) and tumble dried, then cut to swatches of approx.14x14.5cm (total weight of 4 swatches 25g). As a source of carbon black RD-liq 01 from CFT containing 7 g of carbon black liquid (about 33 % carbon black particles) in plastic bottles, that are normally intended for full scale washes in washing machine (one bottle per one single wash with test fabrics), were used. In this Example the method was adapted to small scale using approximately similar ratio of carbon black and water that would be in full scale. First a stock solution carbonblack was prepared by placing an opened bottle of RD- liq 01 (i.e. about 2.3g carbon blackparticles) in a decanter flask containing 1 liter of deionized water. The solution was stirred with a magnetic stirrer for overnight until the contents of the bottle were totally released. After that 65g of stock solution mixed with 935 ml of synthetic tap water with hardness of 17.1°dH ending up to diluted carbon black solution having hardness of 16°dH and carbon black content approximately 0.15g / l (or 0.45 g RD-liq 01). For synthetic tap water with hardness of 17.1°dH the following stock solutions were prepared in deionized water (Milli-Q or equivalent):Stock solution with 1000°d Calcium-hardness: CaCl2 x 2 H2O (1.02382.1000, Merck KgaA,Germany) 26.22 g / lStock solution with 200°d Magnesium-hardness: MgSO4 x 7 H2O (1.05886.1000, MerckKgaA, Germany) 8.79 g / l H2O NaHCO3 stock solution: NaHCO3 (1.06329.1000 Merck KgaA, Germany) 29.6g / l. 14.2ml CaCl2 solution, 14.2ml MgSO4 solution and 10.0ml of freshly made NaHCO3 solution were added in volumetric flask in the given order, made up to 1 liter with deionized water and mixed.Antigreying tests were performed in Atlas LP-2 Launder-Ometer as follows. Launder-Ometer was first preheated to 40°C. 60g of steel balls (diameter 0.6cm), 0.79g of commercial liquid detergent described in Table 2, 250ml of diluted carbon black solutionhaving hardness of 16°dH and diluted enzyme (<1.0ml) were added into 1.2 litercontainers. After that, 4 swatches of prewashed test fabric CN-42 were added and the Launder-Ometer was run at 40°C for 60min with a rotation speed of 42rpm. Enzymes were dosed 0.2 or 0.6 activity units (NCU) per liter. After the cellulase treatment in Launder-Ometer, the swatches were first quickly rinsed separately under running tap water (ca. 20°C) to remove the steel balls, then rinsed separately under running water in specific cups containing holes for 3 times and finally dipped in a bucket containing water. After that the swatches were spin-dried in a washing machine and let to dry on a grid at room temperature. Enzyme treated fabrics and controls without enzyme were rinsed and spin-dried separately to avoid contamination. Antigreying performance of cellulase was evaluated by measuring reflectance of test fabrics by Konica Minolta CM3610A spectrophotometer as Y-value (illuminant D65 / 10°, 420nm cut). Cellulase performance was calculated as ΔY (delta Y), which means value Y of enzyme treated fabric minus value Y of fabric treated with carbon black and detergent containing washing liquor without enzyme (enzyme blank, control). Values were the average of 4 swatches. The higher the Y or ΔY value, the better the antigreying effect and whiteness of the fabric.Results in Table 3 show that the tested variants have at least as good (0) antigreyingperformance compared to parental cellulase AS0 (data not shown). AS58 has betterperformance (+) compared to AS0, when tested with commercial detergent 1.For the rating the performance of the variants in Tables 3 and 5, the following ratingscheme was used:0 (no difference to AS0): + / - 1,5 units (ΔY)+ (better than AS0): +1,5 - 3,5 units (ΔY)++ (clearly better than AS0): +3,5 - 5,5 units (ΔY)+++ (highly improved over AS0): >5,5 units (ΔY) - (weaker performance than AS0): <-1,5 units (ΔY)Table 3. Antigreying performance of the variants in commercial liquid detergent 1Variant code PerformanceAS45 0AS47 0AS51 0AS52 0AS53 0AS57 0AS58 +AS59 0AS73 0Example 6. Testing the antigreying performance of AS variants in Launder-Ometer incommercial detergent 2 AS0 variants (AS45, AS58, AS83-AS113) produced in Trichoderma as described inExample 3 were tested for antigreying performance by a single wash method (40°C,60min, 16°dH) using carbon black (approx. 0.15g / l) in a wash solution in addition to detergent (3.1g / l). Parental cellulase AS0 was used as reference.Cotton interlock double jersey with optical brighteners (CN-42) or cotton interlock doublejersey with optical brighteners, pre-washed 3x with IEC A* (CN-42 (w3x)) supplied from CFT (Center for Testmaterials NV, the Netherlands) was used as test fabric. CN-42 fabricwas prewashed in a washing machine (similar as described in Example 4 or 3 x 1h 40 min90°C with W-IEC A* reference base detergent without phosphate and 1h 40 min 90°C)and tumble dried. Prewashed CN-42 fabric and CN-42(w3x) fabric were cut to swatchesof approx.13.5-14x14.5-16 cm (total weight of 4 swatches 25g). As a source of carbon black RD-liq 01 from CFT containing 7g of carbon black liquid (about 33% carbon black particles) in plastic bottles, that are normally intended for full scale washes in washing machine (one bottle per one single wash with test fabrics), were used. In this Example the method was adapted to small scale using approximately similar ratio of carbon black and water that would be in full scale. First a stock solution carbon blackwas prepared by placing an opened bottle of RD-liq 01 (i.e. about 2.3g carbon blackparticles) in a decanter flask containing 1 liter of deionized water. The solution was stirred with a magnetic stirrer for overnight until the contents of the bottle were totally released. After that 65g of stock solution mixed with 935ml of synthetic tap water with hardness of 17.1°dH ending up to diluted carbon black solution having hardness of 16°dH and carbon black content approximately 0.15g / l (or 0.45g RD-liq 01). For synthetic tap water with hardness of 17.1°dH the following stock solutions were prepared in deionized water (Milli-Q or equivalent):Stock solution with 1000°d Calcium-hardness: CaCl2 x 2 H2O (1.02382.1000, Merck KgaA,Germany) 26.22g / lStock solution with 200°d Magnesium-hardness: MgSO4 x 7 H2O (1.05886.1000, MerckKgaA, Germany) 8.79 g / l H2O NaHCO3 stock solution: NaHCO3 (1.06329.1000 Merck KgaA, Germany) 29.6g / l. 14.2ml CaCl2 solution, 14.2ml MgSO4 solution and 10.0ml of freshly made NaHCO3 solution were added in volumetric flask in the given order, made up to 1 liter with deionized water and mixed. Antigreying tests were performed in Atlas LP-2 Launder-Ometer as follows. Launder- Ometer was first preheated to 40°C. 60g of steel balls (diameter 0.6cm), 0.77g of commercial liquid detergent described in Table 4, 250ml of diluted carbon black solution having hardness of 16°dH and diluted enzyme (<1.0ml) were added into 1.2 liter containers. After that, 4 swatches of prewashed test fabric CN-42 or test fabric CN-42(w3x) were added and the Launder-Ometer was run at 40°C for 60min with a rotationspeed of 42rpm. Enzymes were dosed 0.1, 0.2 or 0.6 activity units (NCU) per liter. Table 4. Composition of commercial liquid detergent 2 Ingredient %Anionic surfactants 5 – 15Nonionic surfactants, soap 5 – 15Boric acid ≤ 0,2Other ingredients: e.g. citric acid, builder, polyols, solvents, optical brighteners, perfumes, preservatives water to 100 % pH 7.5-8.5 After the cellulase treatment in Launder-Ometer, the swatches were first quickly rinsed separately under running tap water (ca. 20°C) to remove the steel balls, then rinsed separately under running water in specific cups containing holes for 3 times and finallydipped in a bucket containing water. After that the swatches were spin-dried in a washingmachine and let to dry on a grid at room temperature. Enzyme treated fabrics and controls without enzyme were rinsed and spin-dried separately to avoid contamination.Antigreying performance of cellulase was evaluated by measuring reflectance of testfabrics by Konica Minolta CM3610A spectrophotometer as Y-value (illuminant D65 / 10°, 420 nm cut). Cellulase performance was calculated as ΔY (delta Y), which means value Y of enzyme treated fabric minus value Y of fabric treated with carbon black and detergent containing washing liquor without enzyme (enzyme blank, control). Values were the average of 4 swatches. The higher the Y or ΔY value, the better the antigreying effect and whiteness of the fabric. Results in Table 5 show that the tested variants could be successfully produced as an active enzyme and they have at least as good (0) antigreying performance compared toparental cellulase AS0 (data not shown). AS58, AS93, AS95 and AS98 have betterperformance (+) compared to AS0. Variants AS101-AS113, which belong to the group of loop truncated AS variants, have clearly improved (++) or highly improved (+++)antigreying performance compared to parental cellulase AS0 when tested with commercialliquid detergent 2.Table 5. Antigreying performance of the variants in commercial liquid detergent 2Variant code PerformanceAS45 0AS58 +AS83 0AS84 0AS85 0AS86 0AS87 0AS88 0AS89 0AS90 0AS91 0AS92 0AS93 +AS94 0AS95 +AS96 0AS97 0AS98 +AS99 0AS100 0AS101 ++AS102 ++AS103 +++AS104 +++AS105 +++The foregoing description has provided by way of non-limiting examples of particular implementations and embodiments a full and informative description of the best mode presently contemplated by the inventors for carrying out the invention. It is however clear to a person skilled in the art that the invention is not restricted to details of the embodiments presented in the foregoing, but that it can be implemented in other embodiments using equivalent means or in different combinations of embodiments without deviating from the characteristics of the invention. Furthermore, some of the features of the afore-disclosed example embodiments may be used to advantage without the corresponding use of other features. As such, the foregoing description shall be considered as merely illustrative of the principles of the present invention, and not in limitation thereof. Hence, the scope of the invention is only restricted by the appended patent claims.
Claims
1. CLAIMS1. A cellulase variant comprising an amino acid sequence having at least 80%sequence identity with the SEQ ID NO: 1, at least a partial absence of amino acids corresponding to positions 274-289 of SEQ ID NO: 1, and having anincreased antigreying performance compared to a cellulase having the SEQ ID NO: 1.
2. The cellulase variant of claim 1 further comprising at least one structuralmodification, wherein the structural modification is one or more substitution selected from 37S / T / N; 236S / P / G; and 239G / S.
3. The cellulase variant of claim 1 further comprising at least one structuralmodification, wherein the structural modification is one or more substitution selected from A37S / T / N; D236S / P / G; and A239G / S.
4. The cellulase variant of claim 2 or 3, wherein the structural modification is amodification in one or two positions selected from 37S / T / N, 236S / P, and 239G, more preferably from A37S / T / N, D236S / P, and A239G.
5. The cellulase variant of any one of claims 1-4 further comprising a trunca-tion of a loop defined by the amino acids 274-289, and wherein the trunca- tion is a substitution of amino acids 274-289 by 1-4 amino acids.
6. The cellulase variant of claim 5, wherein the substitution is selected from(AS101) S274-K287 replaced with NRRG (SEQ ID NO: 4), (AS102) S274- K287 replaced with NDTTG (SEQ ID NO: 5), (AS103) P276-K287 replaced with GG, and (AS104) P276-K287 replaced with GPG.
7. A detergent comprising a cellulase enzyme having an amino acid sequencehaving at least 80% sequence identity with the SEQ ID NO: 1 and / or thecellulase variant of any one of the claims 1-6, and at least one surfactant.
8. The detergent of claim 7, wherein the detergent is provided in a form of abar, a homogenous tablet, a tablet having two or more layers, a pouch hav- ing one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular liquid, compact liquid, or concentrated liquid.
9. The detergent of claim 7 or 8, wherein the detergent is a laundry detergentcomposition, preferably a liquid or solid laundry detergent composition. 10.The detergent of any one of claims 7-9, wherein the detergent further com- prises at least one other enzyme selected from the group of proteases, am- ylases, cellulases, lipases, xylanases, mannanases, cutinases, esterases, phosphodiesterases, phytases, DNases, pectinases, pectate lyases, pec- tinolytic enzymes, carbohydrases, arabinases, galactanases, xanthanases, xyloglucanases, laccases, peroxidases, and oxidases with or without a me- diator.11.The detergent of any one of the claims 7-10 further comprising at least oneadditive selected from the group of stabilizer, buffer, surfactant, builder, bleaching agent, mediator, anticorrosion agent, antiredeposition agent, caustic, abrasive, optical brightener, dye, pigment, and preservative. 12.A method of producing the cellulase variant of any one of the claims 1-6 comprising culturing a recombinant host cell having genetic elements con- figured to express a polypeptide having the amino acid sequence of the cellulase variant of any one of the claims 1-6, and recovering the polypep- tide. 13.A method for antigreying, stain removal, fiber care, color care, biostoning, or biofinishing a cotton containing fabric, comprising a step of contacting the cellulase variant according to any of claims 1-6, or the detergent according claims 7-11, with the cotton containing fabric. 14.The method of claim 13, wherein the cotton containing fabric is a garment, fabric, or yarn containing cotton.
15. A method of generating a cellulase variant comprising the steps of:(a) providing a template nucleic acid sequence of a template cellulase; (b) identifying by biocomputing means active site residues and loop region residues of the template cellulase;(c) generating variant nucleic acid sequences that encode candidate cellu- lase variants by modifying the template nucleic acid sequence by a modifi- cation, deletion, or addition of one or more amino acid in the active site residues and / or in loop region residues; (d) expressing the template nucleic acid sequence in a recombinant host cell to provide template cellulase enzyme; (e) expressing the variant nucleic acid sequences in a recombinant host cell to provide a candidate variant enzyme; (f) testing and scoring the candidate variant enzymes, and using the tem- plate cellulase enzyme as a reference, for production level in the host cell, and antigreying performance, and wherein the testing and scoring optionally comprises testing and scoring for antigreying performance by measuringthe cellulase activity according to the method described in Example 5 and scoring by the following scheme: 0(no difference to AS0): + / - 1,5 units (ΔY)+ (better than AS0): +1,5 - 3,5 units (ΔY)++ (clearly better than AS0): +3,5 - 5,5 units (ΔY)+++ (highly improved over AS0): >5,5 units (ΔY) - (weaker performance than AS0): <-1,5 units (ΔY); and (g) selecting the candidate variant enzyme as the cellulase variant when the candidate variant enzyme reaches a predetermined scoring threshold value based on the performance in step (f), and, optionally, wherein the scoringthreshold value is 0, +, ++, and / or +++, preferably at least +, more preferably at least ++, and most preferably +++.
16. The method of claim 15, wherein the template nucleic acid sequence of the template cellulase encodes SEQ ID NO: 1.
Citation Information
Patent Citations
Variants of Fungal Cellulase
US20190194634A1
Cellulases, the genes encoding them and uses thereof
WO1997014804A1
Novel cell wall deconstruction enzymes of chaetomium olivicolor, acremonium thermophilum, and myceliophthora hinnulea, and uses thereof
WO2016090474A1